Target intelligence / Profile preview

Immune system cell-cell and paracrine interactions

Molecular classification
Other, Cytokine signaling, Cell surface interaction
01

Overview

Immune system cell-cell and paracrine interactions represent the complex network of communication between immune cells and their surrounding environment, rather than a single molecular target (NIH, 2023). This system involves direct physical contact between cells, such as the interaction between T-cell receptors and antigen-presenting cells, as well as the secretion of paracrine factors like cytokines and chemokines (StatPearls, 2023). These interactions are critical for coordinating innate and adaptive immune responses, regulating cell differentiation, and maintaining tissue homeostasis (PubMed, 2022). In pathological states such as chronic inflammation, autoimmunity, and cancer, these signaling pathways are often dysregulated, leading to aberrant immune activation or suppression (Nature Reviews Immunology, 2021). Therapeutic strategies targeting these interactions often involve monoclonal antibodies that block specific cytokines or their receptors, as well as small molecules that inhibit downstream intracellular signaling cascades (Journal of Clinical Investigation, 2020). Because this category represents a broad physiological process, it serves as a conceptual framework for understanding how various drugs modulate the immune environment as a whole.

Other names
Intercellular immune signalingParacrine immune communicationImmune cell-cell crosstalkImmune system interactions
02

Mechanism of action

Drugs targeting these interactions typically function by neutralizing secreted signaling molecules (e.g., cytokines), blocking their respective receptors, or inhibiting the intracellular signaling pathways that mediate the cellular response to these paracrine signals (StatPearls, 2023; PubMed, 2022).

03

Biological functions

Immune responseSignal transductionCell-cell communicationParacrine signalingInflammatory response
04

Disease associations

InflammationAutoimmune diseaseCancerInfectionGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)Increased risk of serious opportunistic infectionsImmune-related adverse events (irAEs)Reactivation of latent tuberculosisInfusion-related reactions
06

Interacting drugs

Infliximab

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) levelsTumor necrosis factor-alpha (TNF-alpha) levelsErythrocyte sedimentation rate (ESR)Soluble IL-2 receptor

Beyond the preview

Go deeper on Immune system cell-cell and paracrine interactions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system cell-cell and paracrine interactions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call